American Eagle’s Partnership with CBD Producer Spurns Complaints from Concerned Parents
The wildly popular cannabinoid is creating lucrative opportunities for investors, but still maintains a dubious status with the Food & Drug Administration.
MORE STORIES LIKE THIS
Featured Franchise News
Featured Brand News
/story1/2710565/8d27c1b49f8d229337f891d1710953086382.jpg)

/story1/2730722/1762465763_2730722.png)
/story1/2730730/1762547985_2730730.png)
/story1/2730837/1764072940_2730837.png)
/story1/2730975/1765487677_2730975.png)
/story1/2730548/1761082102_2730548.png)
/story1/2730966/1765318139_2730966.png)
/story1/2730903/1764716823_2730903.png)
/story1/2730984/1765581777_2730984.png)
/story1/2730983/1765578160_2730983.png)
/story1/2730982/1765573608_2730982.png)
/story1/2730979/1765546185_2730979.png)